3rd Quarter - Report

VENABLE LLP for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to neglected diseases research and development and access; COVID treatments research and development.

LobbyistCovered position, as disclosed
JODIE CURTIS —

Budget/Appropriations BUD

FY 2023 Labor, Health and Human Services, Education, and State and Foreign Operations funding for global health research and development and neglected tropical diseases and Covid treatments; Covid-19 supplemental funding; FY 2024 global health research and development funding; Issues related to global health.

LobbyistCovered position, as disclosed
JODIE CURTIS —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.